Selection of long COVID symptoms influences prevalence estimates in a prospective cohort
Wynberg, E.; de Bree, G. J.; Leenstra, T.; Verveen, A.; van Willigen, H. D. G.; de Jong, M.; Prins, M.; Boyd, A.; the RECoVERED Study Group,
Show abstract
BackgroundStudies on long COVID differ in the selection of symptoms used to define the condition. We aimed to assess to what extent symptom selection impacts prevalence estimates of long COVID. MethodsIn a prospective cohort of patients who experienced mild to critical coronavirus disease 2019 (COVID-19), we used longitudinal data on the presence of 20 different symptoms to evaluate changes in the prevalence of long COVID over time when altering symptom selection. ResultsChanging symptom selection resulted in wide variation in long COVID prevalence, even within the same study population. Long COVID prevalence at 12 months since illness onset ranged from 39.6% (95%CI=33.4-46.2) when using a limited selection of symptoms to 80.6% (95%CI=74.8-85.4) when considering any reported symptom to be relevant. ConclusionsComparing the occurrence of long COVID is already complex due to heterogeneity in study design and population. Disparate symptom selection may further hamper comparison of long COVID estimates between populations. Harmonised data collection tools could be one means to achieve greater reproducibility and comparability of results.
Matching journals
The top 13 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Incidence and severity of SARS-CoV-2 infections in people with primary ciliary dyskinesia 90%
- SARS-CoV-2 quarantine mandated by contact tracing: burden and infection rate among close contacts in Zurich, Switzerland, 2020-2021 89%
- Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection 88%
Similar papers in this journal
- Symptoms at presentation for patients admitted to hospital with Covid-19: results from the ISARIC prospective multinational observational study 94%
- Vaccine effectiveness against severe COVID-19 during the Omicron wave in Germany: Results from the COViK study 91%
- Increased risk of death in covid-19 hospital admissions during the second wave as compared to the first epidemic wave. A prospective dynamic cohort study in South London, UK 90%
Similar papers in this journal
- A cohort study of Post COVID-19 Condition across the Beta, Delta and Omicron waves in South Africa: 6-month follow up of hospitalised and non-hospitalised participants 94%
- No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway 91%
- Day by day symptoms following positive and negative PCR tests for SARS-CoV-2 in non-hospitalised health-care workers: a 90-day follow-up study 90%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.